This special issue of Social Science and Medicine is an extended critical look at RCTs and the What Works industry. Looks interesting.
Paul
Paul Bywaters
Emeritus Professor of Social Work,
Faculty of Health and Life Sciences,
Coventry University,
Priory Street, Coventry CV1 5FB
For information about the Child Welfare Inequalities Project go to www.coventry.ac.uk/CWIP
To join the Child Welfare Inequalities Network go to www.jiscmail.ac.uk and search for ChildWelfareInequalities or email me directly.
________________________________________
From: ScienceDirect Message Center <[log in to unmask]>
Sent: 19 July 2018 20:19
To: Paul Bywaters
Subject: Social Science & Medicine: Alert 12 July-19 July
Can't see this email properly? Click here to view an online version<https://emea01.safelinks.protection.outlook.com/?url=http%3A%2F%2Frt1-t.notifications.elsevier.com%2Fr%2F%3Fid%3Dh7383857%2C5bfc58e%2C5bfc58f%26p1%3D%25409ogKS8nIlKvW2MzSx8zVDVYjCc4K3JyM%252FclYpThfhsE%253D&data=02%7C01%7C%7C2b13601939ac414bb7bf08d5edaca26c%7C4b18ab9a37654abeac7c0e0d398afd4f%7C0%7C0%7C636676248080887919&sdata=KcEjuDAiwtgcXWpF9ahpqCReuJNSOQOgtjTJBg9U5BU%3D&reserved=0>
[ScienceDirect® Home]<https://emea01.safelinks.protection.outlook.com/?url=http%3A%2F%2Frt1-t.notifications.elsevier.com%2Fr%2F%3Fid%3Dh7383857%2C5bfc58e%2C5bfc590&data=02%7C01%7C%7C2b13601939ac414bb7bf08d5edaca26c%7C4b18ab9a37654abeac7c0e0d398afd4f%7C0%7C0%7C636676248080887919&sdata=UGlrgEjanFCF9smQ069Ovxc4Sw568xIqMEtWk1v0T4A%3D&reserved=0>
Alert: Social Science & Medicine
New articles available on ScienceDirect
[Volume 210, Pages 1-90, August 2018] <https://emea01.safelinks.protection.outlook.com/?url=http%3A%2F%2Frt1-t.notifications.elsevier.com%2Fr%2F%3Fid%3Dh7383857%2C5bfc58e%2C5bfc591%26p1%3Dwww.sciencedirect.com%2Fscience%2Fjournal%2F02779536%2F210%2Fsupp%2FC%26dgcid%3Draven_sd_via_email&data=02%7C01%7C%7C2b13601939ac414bb7bf08d5edaca26c%7C4b18ab9a37654abeac7c0e0d398afd4f%7C0%7C0%7C636676248080887919&sdata=mcwPZnAR3e7flLQJcRKnzJm3fS3gwwND8RIQnwTk%2FM8%3D&reserved=0> Social Science & Medicine<https://emea01.safelinks.protection.outlook.com/?url=http%3A%2F%2Frt1-t.notifications.elsevier.com%2Fr%2F%3Fid%3Dh7383857%2C5bfc58e%2C5bfc594%26p1%3Dwww.sciencedirect.com%2Fscience%2Fjournal%2F02779536%26dgcid%3Draven_sd_via_email&data=02%7C01%7C%7C2b13601939ac414bb7bf08d5edaca26c%7C4b18ab9a37654abeac7c0e0d398afd4f%7C0%7C0%7C636676248080887919&sdata=u20LLgizfTKHKHWe1X1uYMxIVt%2BAy%2BBWADR9JdAkc10%3D&reserved=0>
Volume 210, Pages 1-90, August 2018<https://emea01.safelinks.protection.outlook.com/?url=http%3A%2F%2Frt1-t.notifications.elsevier.com%2Fr%2F%3Fid%3Dh7383857%2C5bfc58e%2C5bfc599%26p1%3Dwww.sciencedirect.com%2Fscience%2Fjournal%2F02779536%2F210%2Fsupp%2FC%26dgcid%3Draven_sd_via_email&data=02%7C01%7C%7C2b13601939ac414bb7bf08d5edaca26c%7C4b18ab9a37654abeac7c0e0d398afd4f%7C0%7C0%7C636676248080887919&sdata=DLJEhDQxsX73uUXWG2nxj%2B6BUvoJUORGRbZQH8GbI14%3D&reserved=0>
Randomized Controlled Trials and Evidence-based Policy: A Multidisciplinary Dialogue
Edited by Ichiro Kawachi, S.V. Subramanian and Ryan Mowat
Editorial Board <https://emea01.safelinks.protection.outlook.com/?url=http%3A%2F%2Frt1-t.notifications.elsevier.com%2Fr%2F%3Fid%3Dh7383857%2C5bfc58e%2C5bfc59f%26p1%3Dwww.sciencedirect.com%2Fscience%3F_ob%3DGatewayURL%26_method%3DcitationSearch%26_version%3D1%26_piikey%3DS0277953618303496%26_origin%3DRV_SD_TOC_EMAIL%26dgcid%3Draven_sd_via_email&data=02%7C01%7C%7C2b13601939ac414bb7bf08d5edaca26c%7C4b18ab9a37654abeac7c0e0d398afd4f%7C0%7C0%7C636676248080887919&sdata=TyLFqs3GC8DIopggmVvaLxfN1v7nlVkNPxmDVAFFsm4%3D&reserved=0>
Page ii
Randomized controlled trials and evidence-based policy: A multidisciplinary dialogue <https://emea01.safelinks.protection.outlook.com/?url=http%3A%2F%2Frt1-t.notifications.elsevier.com%2Fr%2F%3Fid%3Dh7383857%2C5bfc58e%2C5bfc59f%26p1%3Dwww.sciencedirect.com%2Fscience%3F_ob%3DGatewayURL%26_method%3DcitationSearch%26_version%3D1%26_piikey%3DS0277953618302387%26_origin%3DRV_SD_TOC_EMAIL%26dgcid%3Draven_sd_via_email&data=02%7C01%7C%7C2b13601939ac414bb7bf08d5edaca26c%7C4b18ab9a37654abeac7c0e0d398afd4f%7C0%7C0%7C636676248080887919&sdata=yQxR93m%2FjoMYJdbOXIXCdNU83tSpqKMz2ye8WLqx1pE%3D&reserved=0>
Page 1
Ryan Mowat, S.V. Subramanian, Ichiro Kawachi
Understanding and misunderstanding randomized controlled trials <https://emea01.safelinks.protection.outlook.com/?url=http%3A%2F%2Frt1-t.notifications.elsevier.com%2Fr%2F%3Fid%3Dh7383857%2C5bfc58e%2C5bfc59f%26p1%3Dwww.sciencedirect.com%2Fscience%3F_ob%3DGatewayURL%26_method%3DcitationSearch%26_version%3D1%26_piikey%3DS0277953617307359%26_origin%3DRV_SD_TOC_EMAIL%26dgcid%3Draven_sd_via_email&data=02%7C01%7C%7C2b13601939ac414bb7bf08d5edaca26c%7C4b18ab9a37654abeac7c0e0d398afd4f%7C0%7C0%7C636676248080887919&sdata=g6IsTB%2Ba8xgTRLvYgArT1%2Biu02qrnGHorDyQ87Lmpm4%3D&reserved=0> Original Research Article
Pages 2-21
Angus Deaton, Nancy Cartwright
Introduction. What works? And for whom? <https://emea01.safelinks.protection.outlook.com/?url=http%3A%2F%2Frt1-t.notifications.elsevier.com%2Fr%2F%3Fid%3Dh7383857%2C5bfc58e%2C5bfc59f%26p1%3Dwww.sciencedirect.com%2Fscience%3F_ob%3DGatewayURL%26_method%3DcitationSearch%26_version%3D1%26_piikey%3DS027795361830248X%26_origin%3DRV_SD_TOC_EMAIL%26dgcid%3Draven_sd_via_email&data=02%7C01%7C%7C2b13601939ac414bb7bf08d5edaca26c%7C4b18ab9a37654abeac7c0e0d398afd4f%7C0%7C0%7C636676248080887919&sdata=R%2BNNmiqx6kd3b8FUK5%2BG0iY6o0UiSg499oDs%2BUvxI0M%3D&reserved=0>
Pages 22-25
Ralph I. Horwitz, Burton Singer
The trials of randomized control: Probability, intuition and the dinosaur risk. A commentary on Deaton and Cartwright <https://emea01.safelinks.protection.outlook.com/?url=http%3A%2F%2Frt1-t.notifications.elsevier.com%2Fr%2F%3Fid%3Dh7383857%2C5bfc58e%2C5bfc59f%26p1%3Dwww.sciencedirect.com%2Fscience%3F_ob%3DGatewayURL%26_method%3DcitationSearch%26_version%3D1%26_piikey%3DS027795361830203X%26_origin%3DRV_SD_TOC_EMAIL%26dgcid%3Draven_sd_via_email&data=02%7C01%7C%7C2b13601939ac414bb7bf08d5edaca26c%7C4b18ab9a37654abeac7c0e0d398afd4f%7C0%7C0%7C636676248080887919&sdata=2mxKssQxtYGwNngZojU%2BdLHVZOF8lTPOSPRo%2FCAjBiY%3D&reserved=0>
Pages 26-28
Kaushik Basu
The potential role for sociologists in designing RCTs and of RCTs in refining sociological theory: A commentary on Deaton and Cartwright <https://emea01.safelinks.protection.outlook.com/?url=http%3A%2F%2Frt1-t.notifications.elsevier.com%2Fr%2F%3Fid%3Dh7383857%2C5bfc58e%2C5bfc59f%26p1%3Dwww.sciencedirect.com%2Fscience%3F_ob%3DGatewayURL%26_method%3DcitationSearch%26_version%3D1%26_piikey%3DS0277953618302120%26_origin%3DRV_SD_TOC_EMAIL%26dgcid%3Draven_sd_via_email&data=02%7C01%7C%7C2b13601939ac414bb7bf08d5edaca26c%7C4b18ab9a37654abeac7c0e0d398afd4f%7C0%7C0%7C636676248080887919&sdata=Jo6W6jxRcP0MqTKij4DCUFulxjCGs62Ap9w37BF%2B7MQ%3D&reserved=0>
Pages 29-31
Chris Bonell, G.J. Melendez-Torres, Stephen Quilley
Randomized trials and evidence in medicine: A commentary on Deaton and Cartwright <https://emea01.safelinks.protection.outlook.com/?url=http%3A%2F%2Frt1-t.notifications.elsevier.com%2Fr%2F%3Fid%3Dh7383857%2C5bfc58e%2C5bfc59f%26p1%3Dwww.sciencedirect.com%2Fscience%3F_ob%3DGatewayURL%26_method%3DcitationSearch%26_version%3D1%26_piikey%3DS0277953618301692%26_origin%3DRV_SD_TOC_EMAIL%26dgcid%3Draven_sd_via_email&data=02%7C01%7C%7C2b13601939ac414bb7bf08d5edaca26c%7C4b18ab9a37654abeac7c0e0d398afd4f%7C0%7C0%7C636676248080887919&sdata=gO2STB5inwonF5oZrCwCwdk86Ad6ZnHy%2B3NmPFbjA60%3D&reserved=0>
Pages 32-36
John Concato, Ralph I. Horwitz
Twenty-six assumptions that have to be met if single random assignment experiments are to warrant “gold standard” status: A commentary on Deaton and Cartwright <https://emea01.safelinks.protection.outlook.com/?url=http%3A%2F%2Frt1-t.notifications.elsevier.com%2Fr%2F%3Fid%3Dh7383857%2C5bfc58e%2C5bfc59f%26p1%3Dwww.sciencedirect.com%2Fscience%3F_ob%3DGatewayURL%26_method%3DcitationSearch%26_version%3D1%26_piikey%3DS0277953618301989%26_origin%3DRV_SD_TOC_EMAIL%26dgcid%3Draven_sd_via_email&data=02%7C01%7C%7C2b13601939ac414bb7bf08d5edaca26c%7C4b18ab9a37654abeac7c0e0d398afd4f%7C0%7C0%7C636676248080887919&sdata=0kaQorfD5a4FR9gVzTb9hEJrWrDdH4xK3NtridwotAI%3D&reserved=0>
Pages 37-40
Thomas D. Cook
Randomization, randomized trials, and analyses using observational data: A commentary on Deaton and Cartwright <https://emea01.safelinks.protection.outlook.com/?url=http%3A%2F%2Frt1-t.notifications.elsevier.com%2Fr%2F%3Fid%3Dh7383857%2C5bfc58e%2C5bfc59f%26p1%3Dwww.sciencedirect.com%2Fscience%3F_ob%3DGatewayURL%26_method%3DcitationSearch%26_version%3D1%26_piikey%3DS0277953618302478%26_origin%3DRV_SD_TOC_EMAIL%26dgcid%3Draven_sd_via_email&data=02%7C01%7C%7C2b13601939ac414bb7bf08d5edaca26c%7C4b18ab9a37654abeac7c0e0d398afd4f%7C0%7C0%7C636676248080887919&sdata=fxS7FqX5Oy8GpA3qk94t7j7IpsNO%2BGXkkG9VwuGAk88%3D&reserved=0>
Pages 41-44
Issa J. Dahabreh
Evidence, policy and politics: A commentary on Deaton and Cartwright <https://emea01.safelinks.protection.outlook.com/?url=http%3A%2F%2Frt1-t.notifications.elsevier.com%2Fr%2F%3Fid%3Dh7383857%2C5bfc58e%2C5bfc59f%26p1%3Dwww.sciencedirect.com%2Fscience%3F_ob%3DGatewayURL%26_method%3DcitationSearch%26_version%3D1%26_piikey%3DS0277953618301928%26_origin%3DRV_SD_TOC_EMAIL%26dgcid%3Draven_sd_via_email&data=02%7C01%7C%7C2b13601939ac414bb7bf08d5edaca26c%7C4b18ab9a37654abeac7c0e0d398afd4f%7C0%7C0%7C636676248080887919&sdata=SR6hIzui9voZfuOifWmFkxFeEXcq%2Fqy4iL9DX452wBU%3D&reserved=0>
Pages 45-47
Jean Drèze
Benefits and limitations of randomized controlled trials: A commentary on Deaton and Cartwright <https://emea01.safelinks.protection.outlook.com/?url=http%3A%2F%2Frt1-t.notifications.elsevier.com%2Fr%2F%3Fid%3Dh7383857%2C5bfc58e%2C5bfc59f%26p1%3Dwww.sciencedirect.com%2Fscience%3F_ob%3DGatewayURL%26_method%3DcitationSearch%26_version%3D1%26_piikey%3DS0277953618302016%26_origin%3DRV_SD_TOC_EMAIL%26dgcid%3Draven_sd_via_email&data=02%7C01%7C%7C2b13601939ac414bb7bf08d5edaca26c%7C4b18ab9a37654abeac7c0e0d398afd4f%7C0%7C0%7C636676248080887919&sdata=uegaymFNLRkl9hGDj0Z6m2fhcWwb%2F%2FGA%2FS0MuGm0xZA%3D&reserved=0>
Pages 48-49
Andrew Gelman
Understanding and misunderstanding randomized controlled trials: A commentary on Deaton and Cartwright <https://emea01.safelinks.protection.outlook.com/?url=http%3A%2F%2Frt1-t.notifications.elsevier.com%2Fr%2F%3Fid%3Dh7383857%2C5bfc58e%2C5bfc59f%26p1%3Dwww.sciencedirect.com%2Fscience%3F_ob%3DGatewayURL%26_method%3DcitationSearch%26_version%3D1%26_piikey%3DS0277953618301953%26_origin%3DRV_SD_TOC_EMAIL%26dgcid%3Draven_sd_via_email&data=02%7C01%7C%7C2b13601939ac414bb7bf08d5edaca26c%7C4b18ab9a37654abeac7c0e0d398afd4f%7C0%7C0%7C636676248080887919&sdata=zgQJtg69JvYb0OHQPYbFj48lKuJaoORQuhKy2E%2FjKMM%3D&reserved=0>
Pages 50-52
Guido Imbens
Randomized controlled trials: Often flawed, mostly useless, clearly indispensable: A commentary on Deaton and Cartwright <https://emea01.safelinks.protection.outlook.com/?url=http%3A%2F%2Frt1-t.notifications.elsevier.com%2Fr%2F%3Fid%3Dh7383857%2C5bfc58e%2C5bfc59f%26p1%3Dwww.sciencedirect.com%2Fscience%3F_ob%3DGatewayURL%26_method%3DcitationSearch%26_version%3D1%26_piikey%3DS0277953618301965%26_origin%3DRV_SD_TOC_EMAIL%26dgcid%3Draven_sd_via_email&data=02%7C01%7C%7C2b13601939ac414bb7bf08d5edaca26c%7C4b18ab9a37654abeac7c0e0d398afd4f%7C0%7C0%7C636676248080887919&sdata=dPgA29k%2F8uSBGvLiRHKTtBNtIBK0gdrMzXljNud5kBY%3D&reserved=0>
Pages 53-56
John P.A. Ioannidis
The tribulations of trials: A commentary on Deaton and Cartwright <https://emea01.safelinks.protection.outlook.com/?url=http%3A%2F%2Frt1-t.notifications.elsevier.com%2Fr%2F%3Fid%3Dh7383857%2C5bfc58e%2C5bfc59f%26p1%3Dwww.sciencedirect.com%2Fscience%3F_ob%3DGatewayURL%26_method%3DcitationSearch%26_version%3D1%26_piikey%3DS027795361830193X%26_origin%3DRV_SD_TOC_EMAIL%26dgcid%3Draven_sd_via_email&data=02%7C01%7C%7C2b13601939ac414bb7bf08d5edaca26c%7C4b18ab9a37654abeac7c0e0d398afd4f%7C0%7C0%7C636676248080887919&sdata=fjV3wCtO6pOhE7fHee1uYVkcKrZpHLh6QriMDQbVHXs%3D&reserved=0>
Pages 57-59
J. Michael Oakes
Challenging the hegemony of randomized controlled trials: A commentary on Deaton and Cartwright <https://emea01.safelinks.protection.outlook.com/?url=http%3A%2F%2Frt1-t.notifications.elsevier.com%2Fr%2F%3Fid%3Dh7383857%2C5bfc58e%2C5bfc59f%26p1%3Dwww.sciencedirect.com%2Fscience%3F_ob%3DGatewayURL%26_method%3DcitationSearch%26_version%3D1%26_piikey%3DS0277953618301916%26_origin%3DRV_SD_TOC_EMAIL%26dgcid%3Draven_sd_via_email&data=02%7C01%7C%7C2b13601939ac414bb7bf08d5edaca26c%7C4b18ab9a37654abeac7c0e0d398afd4f%7C0%7C0%7C636676248081044170&sdata=6PIGonO35GfXUDpxsNTq78pKlPZgZ4ZzOYCZBEsUGbM%3D&reserved=0>
Pages 60-62
Judea Pearl
On randomized experimentation in education: A commentary on Deaton and Cartwright, in honor of Frederick Mosteller <https://emea01.safelinks.protection.outlook.com/?url=http%3A%2F%2Frt1-t.notifications.elsevier.com%2Fr%2F%3Fid%3Dh7383857%2C5bfc58e%2C5bfc59f%26p1%3Dwww.sciencedirect.com%2Fscience%3F_ob%3DGatewayURL%26_method%3DcitationSearch%26_version%3D1%26_piikey%3DS0277953618301977%26_origin%3DRV_SD_TOC_EMAIL%26dgcid%3Draven_sd_via_email&data=02%7C01%7C%7C2b13601939ac414bb7bf08d5edaca26c%7C4b18ab9a37654abeac7c0e0d398afd4f%7C0%7C0%7C636676248081044170&sdata=q6dlTxb5XHaROiE8eArL%2BQaE3ppqLVbusSNMlBIo5IA%3D&reserved=0>
Pages 63-66
Stephen W. Raudenbush
After the experimental turn: A commentary on Deaton and Cartwright <https://emea01.safelinks.protection.outlook.com/?url=http%3A%2F%2Frt1-t.notifications.elsevier.com%2Fr%2F%3Fid%3Dh7383857%2C5bfc58e%2C5bfc59f%26p1%3Dwww.sciencedirect.com%2Fscience%3F_ob%3DGatewayURL%26_method%3DcitationSearch%26_version%3D1%26_piikey%3DS0277953618301783%26_origin%3DRV_SD_TOC_EMAIL%26dgcid%3Draven_sd_via_email&data=02%7C01%7C%7C2b13601939ac414bb7bf08d5edaca26c%7C4b18ab9a37654abeac7c0e0d398afd4f%7C0%7C0%7C636676248081044170&sdata=giCUv7zYQDbE%2BEDUXepmA%2BhJm0lFJUkKt3ehYpYPZRQ%3D&reserved=0>
Pages 67-69
Robert J. Sampson
Selection bias in population-representative studies? A commentary on Deaton and Cartwright <https://emea01.safelinks.protection.outlook.com/?url=http%3A%2F%2Frt1-t.notifications.elsevier.com%2Fr%2F%3Fid%3Dh7383857%2C5bfc58e%2C5bfc59f%26p1%3Dwww.sciencedirect.com%2Fscience%3F_ob%3DGatewayURL%26_method%3DcitationSearch%26_version%3D1%26_piikey%3DS0277953618302144%26_origin%3DRV_SD_TOC_EMAIL%26dgcid%3Draven_sd_via_email&data=02%7C01%7C%7C2b13601939ac414bb7bf08d5edaca26c%7C4b18ab9a37654abeac7c0e0d398afd4f%7C0%7C0%7C636676248081044170&sdata=cgCN8JzWZxzrR4i2aaSIxCf%2Ffm7xQefFd2Hz7908zxU%3D&reserved=0>
Page 70
C. Mary Schooling
Randomized clinical trials and personalized medicine: A commentary on deaton and cartwright <https://emea01.safelinks.protection.outlook.com/?url=http%3A%2F%2Frt1-t.notifications.elsevier.com%2Fr%2F%3Fid%3Dh7383857%2C5bfc58e%2C5bfc59f%26p1%3Dwww.sciencedirect.com%2Fscience%3F_ob%3DGatewayURL%26_method%3DcitationSearch%26_version%3D1%26_piikey%3DS0277953618302004%26_origin%3DRV_SD_TOC_EMAIL%26dgcid%3Draven_sd_via_email&data=02%7C01%7C%7C2b13601939ac414bb7bf08d5edaca26c%7C4b18ab9a37654abeac7c0e0d398afd4f%7C0%7C0%7C636676248081044170&sdata=%2BRINys6gJd2iws5HCrK7N%2FpLL8ZBaDJnIn51I%2FqaPCo%3D&reserved=0>
Pages 71-73
Nicholas J. Schork
A combined theoretical and empirical approach to evidence quality evaluation: A commentary on Deaton and Cartwright <https://emea01.safelinks.protection.outlook.com/?url=http%3A%2F%2Frt1-t.notifications.elsevier.com%2Fr%2F%3Fid%3Dh7383857%2C5bfc58e%2C5bfc59f%26p1%3Dwww.sciencedirect.com%2Fscience%3F_ob%3DGatewayURL%26_method%3DcitationSearch%26_version%3D1%26_piikey%3DS0277953618302028%26_origin%3DRV_SD_TOC_EMAIL%26dgcid%3Draven_sd_via_email&data=02%7C01%7C%7C2b13601939ac414bb7bf08d5edaca26c%7C4b18ab9a37654abeac7c0e0d398afd4f%7C0%7C0%7C636676248081044170&sdata=0tN7vG3OuG6GS71FJakvqtOVgjVIApjMB2GOzZjwIVg%3D&reserved=0>
Pages 74-76
Andrew Jones, Daniel Steel
The “average” treatment effect: A construct ripe for retirement. A commentary on Deaton and Cartwright <https://emea01.safelinks.protection.outlook.com/?url=http%3A%2F%2Frt1-t.notifications.elsevier.com%2Fr%2F%3Fid%3Dh7383857%2C5bfc58e%2C5bfc59f%26p1%3Dwww.sciencedirect.com%2Fscience%3F_ob%3DGatewayURL%26_method%3DcitationSearch%26_version%3D1%26_piikey%3DS0277953618301941%26_origin%3DRV_SD_TOC_EMAIL%26dgcid%3Draven_sd_via_email&data=02%7C01%7C%7C2b13601939ac414bb7bf08d5edaca26c%7C4b18ab9a37654abeac7c0e0d398afd4f%7C0%7C0%7C636676248081044170&sdata=zbwY%2B1xsiBIgA7D1bts%2BO%2BjCzGQDTz0BOiuuzl1GYNs%3D&reserved=0>
Pages 77-82
S.V. Subramanian, Rockli Kim, Nicholas A. Christakis
Mechanisms and uncertainty in randomized controlled trials: A commentary on Deaton and Cartwright <https://emea01.safelinks.protection.outlook.com/?url=http%3A%2F%2Frt1-t.notifications.elsevier.com%2Fr%2F%3Fid%3Dh7383857%2C5bfc58e%2C5bfc59f%26p1%3Dwww.sciencedirect.com%2Fscience%3F_ob%3DGatewayURL%26_method%3DcitationSearch%26_version%3D1%26_piikey%3DS0277953618301904%26_origin%3DRV_SD_TOC_EMAIL%26dgcid%3Draven_sd_via_email&data=02%7C01%7C%7C2b13601939ac414bb7bf08d5edaca26c%7C4b18ab9a37654abeac7c0e0d398afd4f%7C0%7C0%7C636676248081044170&sdata=%2Buv%2FQQ2rRtxnKplfRl%2FK%2B5wZ0QSuQSfRL2SGadc7O98%3D&reserved=0>
Pages 83-85
Etsuji Suzuki, Tyler J. VanderWeele
Reflections on Randomized Control Trials <https://emea01.safelinks.protection.outlook.com/?url=http%3A%2F%2Frt1-t.notifications.elsevier.com%2Fr%2F%3Fid%3Dh7383857%2C5bfc58e%2C5bfc59f%26p1%3Dwww.sciencedirect.com%2Fscience%3F_ob%3DGatewayURL%26_method%3DcitationSearch%26_version%3D1%26_piikey%3DS0277953618302132%26_origin%3DRV_SD_TOC_EMAIL%26dgcid%3Draven_sd_via_email&data=02%7C01%7C%7C2b13601939ac414bb7bf08d5edaca26c%7C4b18ab9a37654abeac7c0e0d398afd4f%7C0%7C0%7C636676248081044170&sdata=WsAvVYEx0Vb%2FWQ4%2B7S5BB9xkG8ckltJOM3H4pK7ktwI%3D&reserved=0>
Pages 86-90
Angus Deaton, Nancy Cartwright
Read the full issue on ScienceDirect<https://emea01.safelinks.protection.outlook.com/?url=http%3A%2F%2Frt1-t.notifications.elsevier.com%2Fr%2F%3Fid%3Dh7383857%2C5bfc58e%2C5bfc5a2%26p1%3Dwww.sciencedirect.com%2Fscience%2Fjournal%2F02779536%2F210%2Fsupp%2FC%26dgcid%3Draven_sd_via_email&data=02%7C01%7C%7C2b13601939ac414bb7bf08d5edaca26c%7C4b18ab9a37654abeac7c0e0d398afd4f%7C0%7C0%7C636676248081044170&sdata=0yQaW1Tb%2B%2BzoS4T4KNXwhzxBh2POFUQ8tq7q39UeneY%3D&reserved=0>
Access the ScienceDirect Info site<https://emea01.safelinks.protection.outlook.com/?url=http%3A%2F%2Frt1-t.notifications.elsevier.com%2Fr%2F%3Fid%3Dh7383857%2C5bfc58e%2C5bfc5a3&data=02%7C01%7C%7C2b13601939ac414bb7bf08d5edaca26c%7C4b18ab9a37654abeac7c0e0d398afd4f%7C0%7C0%7C636676248081044170&sdata=HefI0Nl8JZnyY0WNU0%2FrMJS8fLnF%2Bg0nLT8g4ei7qZ4%3D&reserved=0> if you have questions about this message or other features of this service.
This email has been sent to you by ScienceDirect, a division of Elsevier B.V., Radarweg 29, 1043 NX Amsterdam, The Netherlands, Tel.+31 20 485 3911.
ScienceDirect respects your privacy and does not disclose, rent or sell your personal information to any non-affiliated third parties without your consent, except as may be stated in the ScienceDirect online privacy policy<https://emea01.safelinks.protection.outlook.com/?url=http%3A%2F%2Frt1-t.notifications.elsevier.com%2Fr%2F%3Fid%3Dh7383857%2C5bfc58e%2C5bfc5a4&data=02%7C01%7C%7C2b13601939ac414bb7bf08d5edaca26c%7C4b18ab9a37654abeac7c0e0d398afd4f%7C0%7C0%7C636676248081044170&sdata=CpOfeXBIHP9s76XUQFPTk%2BHvDQPsowiFZVeM8rEgnWA%3D&reserved=0>.
By using email or alert services, you agree to comply with the ScienceDirect Terms and Conditions<https://emea01.safelinks.protection.outlook.com/?url=http%3A%2F%2Frt1-t.notifications.elsevier.com%2Fr%2F%3Fid%3Dh7383857%2C5bfc58e%2C5bfc5a5&data=02%7C01%7C%7C2b13601939ac414bb7bf08d5edaca26c%7C4b18ab9a37654abeac7c0e0d398afd4f%7C0%7C0%7C636676248081044170&sdata=WkpEAm7Iog%2Bs6r9P%2FTqQX2Xzay2PjyWrr%2FMYcGdeAGg%3D&reserved=0>.
To unsubscribe from this alert, please click here<https://emea01.safelinks.protection.outlook.com/?url=http%3A%2F%2Frt1-t.notifications.elsevier.com%2Fr%2F%3Fid%3Dh7383857%2C5bfc58e%2C5bfc5a7%26p1%3Dwww.sciencedirect.com%2Fsdfe%2Falerts%2Funsubscribe%3FsubscriptionID%3D43e31362-1289-462b-b768-2d9dcf7bf178%26hash%3D5f86a1332d66329152419d1a30896250a0e589f1%26dgcid%3Draven_sd_via_email&data=02%7C01%7C%7C2b13601939ac414bb7bf08d5edaca26c%7C4b18ab9a37654abeac7c0e0d398afd4f%7C0%7C0%7C636676248081044170&sdata=hLFTKxd2qdUXrt2Cn8syC2HKEEX0C3XIWYekhie4coM%3D&reserved=0>.
Copyright © 2018 Elsevier B.V. or its licensors or contributors. ScienceDirect ® is a registered trademark of Elsevier B.V.
Subscription ID: 43e31362-1289-462b-b768-2d9dcf7bf178 Webuser ID: 9643431 Results Event ID: ba2425cb-2ea9-472a-8a20-ea640c47b662 Batch ID: 1ca5aefa-f9a9-4446-bf42-2dced1525c30 RTEventId: 72057594337023215
1st for Overseas Student Experiences
based on student trips abroad – HESA 2015/16 UK, published 2017
2nd for Teaching Excellence
Times Higher Education UK (TEF) metrics ranking 2017 – Gold winner
5th UK Student City
QS Best Student Cities Index 2018
13th in Guardian University Guide 2019
of 121 UK institutions ranked
NOTICE
This message and any files transmitted with it is intended for the addressee only and may contain information that is confidential or privileged. Unauthorised use is strictly prohibited. If you are not the addressee, you should not read, copy, disclose or otherwise use this message, except for the purpose of delivery to the addressee.
Any views or opinions expressed within this e-mail are those of the author and do not necessarily represent those of Coventry University.
########################################################################
To unsubscribe from the CHILDWELFAREINEQUALITIES list, click the following link:
https://www.jiscmail.ac.uk/cgi-bin/webadmin?SUBED1=CHILDWELFAREINEQUALITIES&A=1
|
